A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2020
Historique:
received: 06 01 2019
revised: 25 06 2019
accepted: 18 07 2019
pubmed: 17 10 2019
medline: 16 1 2020
entrez: 17 10 2019
Statut: ppublish

Résumé

To evaluate differences in the incidence of benign ureteroenteric stricture, we compared stricture rates of robot-assisted radical cystectomy (RARC) and open radical cystectomy (ORC) using Surveillance, Epidemiology, and End Results-Medicare data. We identified 332 RARC and 1449 ORC performed between 2009 and 2014 to determine stricture rates at 6, 12, and 24 months following surgery. We defined ureteroenteric stricture as the need for procedural intervention. Additionally, we compared the incidence of stricture diagnosis. Multivariable proportional hazards regression was performed to determine factors associated with stricture development. The incidence of ureteroenteric stricture at 6 and 12 months was higher for RARC vs ORC at 12.1% vs 7.0% (P < .01) and 15.0% vs 9.5% (P = .01), respectively. RARC vs ORC stricture incidence at 2 years did not differ significantly at 14.6% vs 11.4% (P = .29). Similarly, the stricture diagnosis rates were significantly lower following ORC at 6, 12, and 24 months (P < .05). In adjusted analysis, RARC (HR 1.64, 95%CI 1.23-2.19) and preoperative hydronephrosis (HR 1.51, 95% CI 1.17-1.94) were associated with the development of stricture. Higher hospital volume was associated with a lower risk of stricture (HR 0.40, 95%CI 0.26-0.63). RARC is associated with a higher rate of ureteroenteric stricture diagnosis and intervention on a population-based level that is mitigated by higher hospital volume. A significant study limitation is inability to differentiate extracorporeal vs intracorporeal diversion. However, a stricture complication compounds the financial burden of care and efforts must be pursued to improve this surgical outcome.

Identifiants

pubmed: 31618656
pii: S0090-4295(19)30871-4
doi: 10.1016/j.urology.2019.07.054
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-65

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Alvin C Goh (AC)

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Andre Belarmino (A)

Weill Cornell Medical College, New York, NY.

Neal A Patel (NA)

Department of Urology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY.

Tianyi Sun (T)

Department of Health Policy, Weill Cornell Medicine, New York, NY.

Art Sedrakyan (A)

Department of Health Policy, Weill Cornell Medicine, New York, NY.

Bernard H Bochner (BH)

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Jim C Hu (JC)

Department of Urology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY. Electronic address: Jch9011@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH